Cellectar to present Phase 2 iopofosine data at WM workshop

September 29, 2026 7:30 AM

Cellectar Biosciences (NASDAQ: CLRB) announced it will present a subset analysis from its Phase 2 CLOVER WaM clinical trial at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found